Hydrocortisone and Methylprednisolone Interaction
Drug interaction information between Hydrocortisone and Methylprednisolone.
Hydrocortisone and Methylprednisolone have a documented minor interaction in FDA labeling.
FDA drug labeling documents a minor-severity interaction between Hydrocortisone and Methylprednisolone. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
Using these two steroid medications together can increase the risk of heart failure and an enlarged heart. These medications can cause the body to hold onto fluid, which puts extra stress on the heart.
What To Do
Your doctor should monitor your heart health closely and may need to adjust your medication doses.
FDA Label Information
There have been cases reported in which concomitant use of amphotericin B and hydrocortisone was followed by cardiac enlargement and congestive heart failure.
Hydrocortisone Also Interacts With
- Theophylline major
- Colestipol minor
- Dexamethasone minor
- Meperidine minor
Methylprednisolone Also Interacts With
- Theophylline major
- Aspirin moderate
- Ketoconazole moderate
- Aprepitant moderate
- Clarithromycin moderate
Frequently Asked Questions
Can I take Hydrocortisone and Methylprednisolone together?
This is a minor interaction. Your doctor should monitor your heart health closely and may need to adjust your medication doses.
How serious is the interaction between Hydrocortisone and Methylprednisolone?
This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.
Why do Hydrocortisone and Methylprednisolone interact?
Using these two steroid medications together can increase the risk of heart failure and an enlarged heart. These medications can cause the body to hold onto fluid, which puts extra stress on the heart.
Understanding the Hydrocortisone and Methylprednisolone Interaction
FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Hydrocortisone belongs to the Corticosteroid class and Methylprednisolone belongs to the Corticosteroid class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Using these two steroid medications together can increase the risk of heart failure and an enlarged heart. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Hydrocortisone has 5 total documented interactions on file in this dataset, and Methylprednisolone has 29. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor should monitor your heart health closely and may need to adjust your medication doses. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Hydrocortisone or Methylprednisolone based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.